Exhibits
10-Q
from 10-Q
50 pages
10-Q
08/06/24
EX-4.3
from 10-Q
5 pages
Supplemental Indenture No. 1
08/06/24
EX-10.1
from 10-Q
5 pages
Mallinckrodt Pharmaceuticals 2024 Stock and Incentive Plan (“Plan”) Terms and Conditions of Amended and Restated Restricted Unit Award
08/06/24
EX-10.2
from 10-Q
5 pages
Mallinckrodt Pharmaceuticals 2024 Stock and Incentive Plan (“Plan”) Terms and Conditions of Amended and Restated Restricted Unit Award
08/06/24
EX-10.3
from 10-Q
4 pages
Mallinckrodt Pharmaceuticals 2024 Stock and Incentive Plan (“Plan”) Terms and Conditions of Amended and Restated Restricted Unit Award
08/06/24
EX-10.4
from 10-Q
7 pages
Mallinckrodt Pharmaceuticals 2024 Stock and Incentive Plan (“Plan”) Terms and Conditions of Amended and Restated Performance Restricted Unit Award December 30, 2023 – December 25, 2026 Performance Cycle
08/06/24
EX-10.5
from 10-Q
7 pages
Mallinckrodt Pharmaceuticals 2024 Stock and Incentive Plan (“Plan”) Terms and Conditions of Amended and Restated Performance Restricted Unit Award December 30, 2023 – December 25, 2026 Performance Cycle
08/06/24
EX-10.6
from 10-Q
7 pages
Mallinckrodt Pharmaceuticals 2024 Stock and Incentive Plan (“Plan”) Terms and Conditions of Amended and Restated Performance Restricted Unit Award December 30, 2023 – December 25, 2026 Performance Cycle
08/06/24
EX-10.7
from 10-Q
11 pages
Mallinckrodt Plc Amended and Restated Long-Term Transaction Incentive Plan
08/06/24
EX-31.1
from 10-Q
1 page
Management certification of annual or quarterly disclosure
08/06/24
EX-31.2
from 10-Q
1 page
Management certification of annual or quarterly disclosure
08/06/24
EX-32.1
from 10-Q
1 page
Management certification of financial report
08/06/24
